Promoter group entity Fosun Pharma Industrial Pte. Ltd. sold 98.97 lakh shares of Gland Pharma Limited for approximately ₹2,943.6 Cr in the open market, reducing its stake from 51.76% to 45.76%.
A vertically integrated injectable-focused pharmaceutical company, Gland Pharma develops, manufactures, and markets complex injectables for global markets across the United States, Europe, Canada, Australia, and India. Established in Hyderabad in 1978, the company operates on a business-to-business model and serves customers in over 60 countries worldwide. Known for its expertise in complex injectable formulations, it maintains a strong presence across the value chain. Gland Pharma is promoted by Shanghai Fosun Pharma, a global pharmaceutical major.